Sahajanand Medical Technologies Announces IPO Price Band of Rs 327-344, Opening October 15
Sahajanand Medical Technologies Limited has announced a price band of Rs 327-344 per equity share for its upcoming initial public offering (IPO), which opens for subscription on Thursday, October 15, 2026. The company aims to raise Rs 475.48 crore through an offer for sale (OFS) totaling up to 1,38,22,116 equity shares. Notably, this IPO will not generate proceeds for the company itself, as the funds will be directed to the selling shareholders, including the promoter Shree Hari Trust and various institutional investors. The subscription window is set to close on Monday, October 19, 2026, and the shares are expected to list on the BSE and NSE on Thursday, October 22, 2026.
The allocation of shares will be structured with a focus on ensuring participation from various investor categories. A maximum of 50% of the net offer is earmarked for qualified institutional buyers (QIBs), while at least 15% will be reserved for non-institutional investors (NIIs) and a minimum of 35% for retail individual investors. Given the robust performance in the fiscal year, where the company reported a significant profit increase alongside rising revenues, this IPO could be appealing to investors seeking exposure in the medical devices sector.
Grey market sentiment around Sahajanand Medical Technologies’ IPO has been cautiously optimistic, reflecting investor interest driven by the company’s impressive financial performance. The anticipated demand may indicate a potential for positive listing gains, appealing particularly to retail investors looking to diversify their portfolios into the healthcare sector. Overall, this IPO presents an opportunity for investors to tap into a growing market while carefully assessing the fundamentals of the company.
• WEALTHOVA INSIGHTS
Investors should assess the strong financial growth reported by Sahajanand Medical Technologies when considering participation in this IPO. The strategic allocation frameworks also highlight a balanced approach to investor interests, making it a worthy addition for those looking to invest in the growing medical devices sector.
Disclaimer: Market insights and analyses on Wealthova are strictly for educational and informational purposes and do not constitute financial or investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)

